The latest news and updates about NYSCF and our collaborators
The Problem: For decades, scientists have grappled with the mystery of facial recognition: how our brains turn visual information into memories. At one time, many hypothesized...
The Problem: For patients with paralysis or diseases that impact muscle movement such as ALS, Parkinson’s, or cerebral palsy, the lack of effective ways to communicate...
When Katie Reggio joined NYSCF’s Global Stem Cell Array® team in 2015, she was looking to learn more about stem cells and herself. While she originally...
NYSCF – Robertson Stem Cell Investigator Alumnus, Board member, and Moderna founder Derrick Rossi, PhD, will receive the prestigious Princess of Asturias Award, a recognition given...
The Problem: If you’ve set up your phone to unlock when it sees your face, then you’re already familiar with image recognition technology. Image recognition software...
Camille Fulmore has always known she wanted to be a scientist. Her initial dream of becoming the first woman on Mars may not have come true...
We are proud of our scientists and Innovator community who are hard at work developing solutions for those impacted by COVID-19. This ranges from better diagnosing...
The Problem: Patients suffering from lung failure are often put on ventilators, but as we have seen during the COVID-19 pandemic, these tools aren’t always readily...
Artificial intelligence (AI) is helping scientists take biological research to a whole new level. A finely-tuned algorithm can help identify features of cells imperceptible to the...
The Problem: Our skin serves as an important barrier between us and the outside world, preventing a large array of possible infections from harming us. How...
It’s a difficult time for mental health: the social isolation, fear, and economic fallouts surrounding COVID-19 have ushered in a wave of anxiety, depression, and addiction...
Why do some people develop Parkinson’s disease (PD) while others do not? The answer involves a complex interplay between genetics, aging, and other factors. Stem cells...
Every multiple sclerosis (MS) patient has a different experience, and understanding these experiences is imperative for effectively treating all patients. How can we repair the neurodegeneration...
The Problem: We’ve all heard of – or experienced – hair loss due to stress. But the reasons behind this phenomenon have been unexplored. The Study:...
With more than 6 million bone fractures occurring in the United States each year and more than 200 million people worldwide suffering from osteoporosis, we are...
Watch the Fireside Chat video and read the summary below. We are in something of a race between COVID-19 vaccines and emerging virus variants, and many questions still...
Age-related macular degeneration (AMD) is a leading cause of vision loss, and those over the age of 75 have a nearly 30% risk of being affected....
For patients with age-related macular degeneration (AMD), a cell therapy in development at the NYSCF Research Institute could provide what sounds like a miracle: the restoration...
The New York Stem Cell Foundation (NYSCF) today announced that they are developing a stem cell therapy to treat patients suffering from age-related macular degeneration (AMD)....
A diverse scientific community is essential to create and advance the biomedical breakthroughs that are so urgently needed in our complex and evolving world. In this...
Rare diseases are anything but rare – with more than 7,000 uniquely identified, they cumulatively affect more than 300 million patients worldwide. The majority of these...
We are pleased to announce that Marissa Scavuzzo, PhD, a 2019 NYSCF–Druckenmiller Fellow, is a recipient of the Hanna H. Gray fellowship award. The Howard Hughes...
At the root of every major disease of our time is the simple question: what is going wrong with our cells? Once scientists know exactly how...
There is finally a light at the end of the COVID-19 pandemic tunnel, thanks to a historic vaccine development effort. What will it take to bring...
The New York City Economic Development Corporation (NYCEDC) announced an investment in four new biotech research and development facilities, including the NYSCF Research Institute. This grant...
